Form 8-K - Current report:
SEC Accession No. 0001193125-25-096703
Filing Date
2025-04-25
Accepted
2025-04-25 16:02:20
Documents
13
Period of Report
2025-04-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d933973d8k.htm   iXBRL 8-K 22974
  Complete submission text file 0001193125-25-096703.txt   140556

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA qttb-20250425.xsd EX-101.SCH 2848
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE qttb-20250425_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qttb-20250425_pre.xml EX-101.PRE 10811
16 EXTRACTED XBRL INSTANCE DOCUMENT d933973d8k_htm.xml XML 3522
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Filer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38433 | Film No.: 25873690
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)